Search research articles
Contact Us
Filters
Showing results (121-130 of 303) with videos related to
Page
of 31
Sort By:
The American Journal of Gastroenterology
|
August 10, 2005
Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus
Akihiro Tamori, Shuhei Nishiguchi, Susumu Shiomi, et al.
Histology and Histopathology
|
September 18, 2020
Cytoglobin-expressing cells in the splenic cords contribute to splenic fibrosis in cirrhotic patients
Yuji Iimuro, Akito Yada, Toshihiro Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 16, 2013
Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011
Makoto Shiraki, Shuhei Nishiguchi, Masaki Saito, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
April 30, 2003
Association of HLA alleles with response (especially biochemical response) to interferon therapy in Japanese patients with chronic hepatitis C
Shuhei Nishiguchi, Satoshi Kaneshiro, Motoharu Tanaka, et al.
Surgery Today
|
March 18, 2005
Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B
Shoji Kubo, Hiromu Tanaka, Taichi Shuto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 17, 2010
Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, et al.
Hepatology (Baltimore, Md.)
|
September 1, 2012
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice
Junko Kato, Tomohiro Okamoto, Hiroyuki Motoyama, et al.
Journal of Gastroenterology
|
August 2, 2012
Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B
Masaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 24, 2008
Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial
Masaru Enomoto, Akihiro Tamori, Madoka Toyama Kohmoto, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
April 18, 2015
Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection
Masaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, et al.
Page
of 31
Search research articles
Search
Showing results (121-130 of 303) with videos related to
Sort By:
Page
of 31
The American Journal of Gastroenterology
|
August 10, 2005
Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus
Akihiro Tamori, Shuhei Nishiguchi, Susumu Shiomi, et al.
Histology and Histopathology
|
September 18, 2020
Cytoglobin-expressing cells in the splenic cords contribute to splenic fibrosis in cirrhotic patients
Yuji Iimuro, Akito Yada, Toshihiro Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 16, 2013
Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011
Makoto Shiraki, Shuhei Nishiguchi, Masaki Saito, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
April 30, 2003
Association of HLA alleles with response (especially biochemical response) to interferon therapy in Japanese patients with chronic hepatitis C
Shuhei Nishiguchi, Satoshi Kaneshiro, Motoharu Tanaka, et al.
Surgery Today
|
March 18, 2005
Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B
Shoji Kubo, Hiromu Tanaka, Taichi Shuto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 17, 2010
Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, et al.
Hepatology (Baltimore, Md.)
|
September 1, 2012
Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice
Junko Kato, Tomohiro Okamoto, Hiroyuki Motoyama, et al.
Journal of Gastroenterology
|
August 2, 2012
Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B
Masaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 24, 2008
Optimal duration of additional therapy after biochemical and virological responses to lamivudine in patients with HBeAg-negative chronic hepatitis B: a randomized trial
Masaru Enomoto, Akihiro Tamori, Madoka Toyama Kohmoto, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
April 18, 2015
Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection
Masaru Enomoto, Shuhei Nishiguchi, Akihiro Tamori, et al.
Page
of 31